Jazz Pharmaceuticals plc — Director's Dealing 2016

Feb 11, 2016

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2015-12-31

Reporting Person: Hooper Suzanne Sawochka (EVP & General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-07	Ordinary Shares	G	260.0	$0.0	Disposed	35647	Direct

Footnotes

F1: Includes 52 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2015.